SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-055535
Filing Date
2013-10-29
Accepted
2013-10-29 19:15:35
Documents
1
Period of Report
2013-10-25

Document Format Files

Seq Description Document Type Size
1 AUERBACH F4 rrd393676.html 4  
1 AUERBACH F4 rrd393676.xml 4 4121
  Complete submission text file 0001181431-13-055535.txt   5599
Mailing Address 10940 WILSHIRE BLVD. SUITE 600 LOS ANGELES CA 90024
Business Address
AUERBACH ALAN H (Reporting) CIK: 0001358285 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35703 | Film No.: 131177473

Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations